SB 2738 would create the Mississippi Kratom Consumer Protection Act and establish a regulatory framework for kratom products sold in the state. The bill defines kratom products as consumable food products or dietary ingredients containing Mitragyna species leaf material or extract, and it applies to processors and retailers that sell, prepare, distribute, or advertise those products.
The bill prohibits the sale of kratom products that are adulterated or contaminated with dangerous non-kratom substances, that contain more than 2% 7-hydroxymitragynine in the alkaloid fraction, that include synthetic alkaloids or synthetically derived kratom compounds, or that lack adequate consumer labeling, including a recommended serving size. It also bars sales to anyone under 21 and authorizes the Mississippi Department of Health to administer the act and adopt rules for enforcement. Violations of the product-safety provisions can result in administrative fines of up to $1,000 for a first offense and $5,000 for repeat offenses, with a good-faith reliance defense available to retailers in some circumstances.
Impact
If enacted, the bill would add a new chapter of state-level consumer protection rules specifically for kratom, creating product standards, age restrictions, labeling requirements, and enforcement authority under the Department of Health. It would affect kratom manufacturers, processors, distributors, retailers, and consumers by imposing compliance obligations and penalties for unsafe or noncompliant products, while also referencing existing controlled-substance-related statutes for prohibited contaminants.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the measure appears to be framed as a consumer-safety and product-regulation bill rather than a prohibition bill. The overall tone is protective and regulatory, aiming to allow kratom sales under defined safety standards. No formal opposition or support is documented in the provided context, so the public or legislative sentiment cannot be measured beyond the bill’s consumer-protection framing.
Contention
The main points of potential contention are likely to be the scope of regulation and the scientific/market implications of the product standards. Retailers and kratom sellers may be concerned about compliance costs, the 21-and-over sales restriction, the 2% 7-hydroxymitragynine threshold, and the ban on synthetic alkaloids, while public health advocates may support those restrictions as necessary to reduce adulteration and youth access. The bill also creates a retailer good-faith defense, which suggests concern about downstream liability when sellers rely on supplier representations.